STOCK TITAN

KORU Medical Systems to Report First Quarter 2021 Financial Results on May 12, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

KORU Medical Systems (NASDAQ: KRMD) will announce its Q1 2021 financial results on May 12, 2021. The results will be discussed during a conference call at 4:30 p.m. ET, providing an opportunity for management to give updates on the company’s performance and future plans. KORU Medical specializes in specialty infusion solutions that enhance the quality of life for patients. Their product line includes the FREEDOM Syringe Infusion System, designed for home and alternate care settings.

Positive
  • Scheduled announcement of Q1 2021 financial results on May 12, 2021.
Negative
  • None.

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today announced that the Company will report first quarter 2021 financial results on Wednesday, May 12, 2021. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Conference Call and Webcast Details

The conference call can be accessed by dialing (877) 407-0784 for participants in the U.S. or Canada and (201) 689-8560 for international callers, using conference ID 13718682. A live and archived webcast of the event can be accessed via the IR Calendar on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com. The archived webcast will be available for six months.

About KORU Medical Systems

KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing and HIgH-Flo Subcutaneous Safety Needle Sets. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.

FAQ

When will KORU Medical Systems report its Q1 2021 financial results?

KORU Medical Systems will report its Q1 2021 financial results on May 12, 2021.

What time is KORU Medical's conference call for Q1 2021 results?

The conference call for KORU Medical's Q1 2021 results is scheduled for 4:30 p.m. ET on May 12, 2021.

How can I access KORU Medical's Q1 2021 results conference call?

You can access KORU Medical's conference call by dialing (877) 407-0784 for U.S. callers or (201) 689-8560 for international callers, using conference ID 13718682.

What products does KORU Medical Systems offer?

KORU Medical Systems offers the FREEDOM Syringe Infusion System, which includes FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, among others.

KORU Medical Systems, Inc.

NASDAQ:KRMD

KRMD Rankings

KRMD Latest News

KRMD Stock Data

175.56M
42.95M
6.3%
54.38%
1.06%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
MAHWAH